Second, based on the known signal activation of ROS, TLR4, NLRP3, and lncRNAs, efforts should be made to discover more small molecules or targeted drugs that can regulate the pathways of DKD-related inflammasomes, thereby bringing new methods and hope for the treatment of DKD. The gene discussed is NLRP3; the disease is diabetic kidney disease.